Stephen Penrose

Stephen Penrose has over 20 years of experience in the pharmaceutical industry. Stephen is currently the Head of Chemistry at Nanna Therapeutics, a position they have held since 2022. Prior to this, they worked at Anima Biotech as a Medicinal Chemistry Lead and Senior Research Scientist from 2021 to 2022. During their time at Anima Biotech, they were responsible for the discovery of small molecule mRNA drugs and collaborated with global partners and big pharma companies on novel translation targets.

Before joining Anima Biotech, Stephen held positions at Charles River Laboratories as a Manager of Medicinal Chemistry from 2018 to 2021 and as a Senior Scientist from 2010 to 2018. Stephen also worked as a Synthetic Scientist at BioFocus DPI AG from 2008 to 2010.

Stephen's career began with a PhD CASE Placement at GSK in 2005 and a placement at Pfizer as an Associate Analytical Chemist from 2002 to 2003. At Pfizer, they focused on analytical chromatographic techniques and was involved in routine sample running and maintenance of analytical systems.

Overall, Stephen Penrose has a diverse background in medicinal chemistry and pharmaceutical research, with extensive experience in leading drug discovery projects and collaborating with global partners and big pharma companies.

Stephen Penrose attended Sir Thomas Rich's Grammar School from 1992 to 2000. Stephen then pursued a Bachelor's degree in Chemistry with Management at the University of Bath from 2000 to 2004, during which they completed a 1-year industrial placement. Following their undergraduate studies, Stephen Penrose continued their education at the University of Bath from 2004 to 2008 and obtained a Doctor of Philosophy (PhD) degree in the field of Recent Advances in Rhodium-Catalysed Conjugate Addition Reactions.